The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Abstract
Background Reliable information on causes of death is essential to the development of national and international health policies for prevention and control of disease and injury. Medically certified information is available for less than 30% of the estimated 50.5 million deaths that occur each year worldwide. However, other data sources can be used to develop cause-of-death estimates for populations. To be useful, estimates must be internally consistent, plausible, and reflect epidemiological characteristics suggested by community-level data. The Global Burden of Disease Study (GBD) used various data sources and made corrections for miscoding of important diseases (eg, ischaemic heart disease) to estimate worldwide and regional cause-of-death.patterns in 1990 for 14 age-sex groups in eight regions, for 107 causes.Methods Preliminary estimates were developed with available vital-registration data, sample-registration data for India and China, and small-scale population-study data sources. Registration data were corrected for miscoding, and Lorenz-curve analysis was used to estimate cause-of-death patterns in areas without registration. Preliminary estimates were modified to reflect the epidemiology of selected diseases and injuries. Final estimates were checked to ensure that numbers of deaths in specific age-sex groups did not exceed estimates suggested by independent demographic methods.Findings 98% of all deaths in children younger than 15 years are in the developing world. 83% and 59% of deaths at 15-59 and 70 years, respectively, are in the developing world. The probability of death between birth and 15 years ranges from 22.0% in sub-Saharan Africa to 1.1% in the established market economies. Probabilities of death between 15 and 60 years range from 7.2% for women in established market economies to 39.1% for men in sub-Saharan Africa. The probability of a man or woman dying from a non-communicable disease is higher in sub-Saharan Africa and other developing regions than in established market economies. Worldwide in 1990, communicable, maternal, perinatal, and nutritional disorders accounted for 17.2 million deaths, non-communicable diseases for 28.1 million deaths and injuries for 5.1 million deaths. The leading causes of death in 1990 were ischaemic heart disease (6.3 million deaths), cerebrovascular accidents (4.4 million deaths), lower respiratory infections (4.3 million), diarrhoeal diseases (2.9 million), perinatal disorders (2.4 million), chronic obstructive pulmonary disease (2.2 million), tuberculosis (2.0 million), measles (1.1 million), road-traffic accidents (1.0 million), and lung cancer (0.9 million).Interpretation Five of the ten leading killers are communicable, perinatal, and nutritional disorders largely affecting children. Non-communicable diseases are, however, already major public health challenges in all regions. Injuries, which account for 10% of global mortality, are often ignored as a major cause of death and may require innovative strategies to reduce their toll. The estimates by cause have wide Cls, but provide a foundation for a more informed debate on public-health priorities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beneficial or detrimental, dependent on level and patterns of drinking”
From The relationship between different dimensions of alcohol use and the burden of disease—an update (2017) · cites this paper as [372]
Citations
Cites
(1996) · Cited by 6,884
Self-citationThe Epidemiologic Transition: A Theory of the Epidemiology of Population Change
Omran, A. R. (2005) · Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00398.x · Cited by 3,986
The Epidemiologic Transition: A Theory of the Epidemiology of Population Change
Omran, A. R. (1971) · The Milbank Memorial Fund Quarterly · doi:10.2307/3349375 · Cited by 2,921
World development report 1993 : investing in health
Berkley, S., Bobadilla, J., Hecht, R., Hill, K., Jamison, D. T. T., Murray, C. J. L., Musgrove, P., Saxenian, H., & Tan, J. (1993) · Cited by 2,402
Self-citationQuantifying the burden of disease: the technical basis for disability-adjusted life years.
Murray, C. J. (1994) · PubMed · Cited by 1,556
Self-citationDisability-adjusted life years: a critical review
Anand, S., & Hanson, K. (1997) · Journal of Health Economics · doi:10.1016/s0167-6296(97)00005-2 · Cited by 821
Disease and Mortality in Sub-Saharan Africa
Good, C. M., Feachem, R. G., & Jamison, D. T. T. (1993) · African Studies Review · doi:10.2307/524757 · Cited by 476
Murray, C. J. L., & López, A. D. (1996) · Cited by 474
Self-citationRoss, D. A., Dollimore, N., Smith, P. G., Kirkwood, B. R., Arthur, P., Morris, S. S., Addy, H. A., Binka, F., Arthur, P., Gyapong, J. O., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91879-q · Cited by 384
Health transition in middle-income countries: new challenges for health care
Frenk, J. M., Bobadilla, J. L., SEPUúLVEDA, J., & CERVANTES, M. L. (1989) · Health Policy and Planning · doi:10.1093/heapol/4.1.29 · Cited by 342
Research works printed but not linked: 1
- Lopez, 1983, A note on estimating the cause of death structure in high mortality populatons, Pop Bull United Nat, 14, 66
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Fukuyama, Y., King, J. D., Kataoka, K., Kobayashi, R., Gilbert, R. S., Hollingshead, S. K., Briles, D. E., & Fujihashi, K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002837 · Cited by 57
“40,000 deaths in the United States each year (1).”
BackgroundViewpoint: Evaluating the impact of malaria control efforts on mortality in sub‐Saharan Africa
Rowe, A. K., Steketee, R. W., Arnold, F., Wardlaw, T., Basu, S., Bakyaita, N. N., Lama, M., Winston, C. A., Lynch, M. C., Cibulskis, R. E., et al. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01961.x · Cited by 60
“Death registration systems miss many deaths, and the accuracy of reported causes of deaths is difficult to assess (Mung’ala & Snow 1994; Murray & Lopez 1997; Murray et al. 2001; Reyburn et al. 2004; Mathers et al. 2005).”
Ninomiya, T., Zoungas, S., Neal, B. C., Woodward, M., Patel, A. A., Perkovic, V., Cass, A., Cooper, M. E., Grobbee, D. E., Hamet, P., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328338a89c · Cited by 57
Chronic Obstructive Pulmonary Disease Outcome Measurements: What's Important? What's Useful?
Gross, N. J. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-036sr · Cited by 57
Martínez‐Vila, E., & Irimia, P. (2003) · Cerebrovascular Diseases · doi:10.1159/000074804 · Cited by 57
Awareness of Risk Factors and Warning Signs of Stroke in a Nigeria University
Obembe, A. O., Olaogun, M. O. B., Bamikole, A. A., Komolafe, M. A., & Odetunde, M. O. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.06.036 · Cited by 57
Low bone mineral density in men with chronic obstructive pulmonary disease
Duckers, J. M., Evans, B. A. J., Fraser, W. D., Stone, M. D., Bolton, C. E., & Shale, D. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-101 · Cited by 57
“Background Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide [1].”
BackgroundImpact of Aortic Stiffness on Ischemic Stroke in Elderly Patients
Sugioka, K., Hozumi, T., Sciacca, R. R., Miyake, Y., Titova, I. V., Gaspard, G., Sacco, R. L., Homma, S., & Tullio, M. R. D. (2002) · Stroke · doi:10.1161/01.str.0000021410.83049.32 · Cited by 57
Dwivedi, A. M., Upadhyay, S., Johanson, G., Ernstgård, L., & Palmberg, L. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.09.016 · Cited by 57
Risk factors for stroke and predictors of one-month mortality.
Ong, T.-Z., & Raymond, A. A. (2002) · PubMed · Cited by 57
Systemic therapies for hepatocellular carcinoma
Palmer, D. H., Hussain, S. A., & Johnson, P. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.12.1555 · Cited by 57
“It is estimated that there are approximately half a million new cases of HCC per year [1].”
BackgroundFrikke‐Schmidt, R., Nordestgaard, B. G., Schnohr, P., Steffensen, R., & Tybjærg‐Hansen, A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.066 · Cited by 58
Dey, S. K., Shimizu, H., Phan, T. G., Hayakawa, Y., Islam, A. B. M. M. K., Salim, A. F. M., Khan, A. R., Mizuguchi, M., Okitsu, S., & Ushijima, H. (2009) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2009.02.001 · Cited by 57
“Acute gastroenteritis consistently ranks as one of the top six causes of all deaths (Murray and Lopez, 1997).”
BackgroundAntioxidant therapy for the prevention of cardiovascular disease
Nuttall, S. L. (1999) · QJM · doi:10.1093/qjmed/92.5.239 · Cited by 58
Geethanjali, F. S., Luthra, K., Lingenhel, A., Kanagasabapathy, A. S., Jacob, J., Srivastava, L. M., Vasisht, S., Kraft, H.-G., & Utermann, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00143-6 · Cited by 57
Regular review: Prevention of ischaemic stroke
Gubitz, G. J., & Sandercock, P. A. (2000) · BMJ · doi:10.1136/bmj.321.7274.1455 · Cited by 57
Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis
Ahmed, Z. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.02.002 · Cited by 61
Comorbidities of Chronic Obstructive Pulmonary Disease in Koreans: A Population-Based Study
Joo, H., Park, J., Lee, S., & Oh, Y. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.8.901 · Cited by 56
“The prevalence of COPD is increasing at a greater rate than is the case for other chronic diseases, and COPD is predicted to be the third most frequent cause of deaths worldwide by 2020 (1).”
Sphingolipids and atherosclerosis
Hornemann, T., & Worgall, T. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.041 · Cited by 60
“Atherosclerosis is the most common cause for cardiovascular disease, and one of the leading causes of death worldwide [1,2].”
BackgroundQin, X., Zhang, H., Zhou, X., Wang, C., Zhang, H., Zhang, X., & Ye, L. (2007) · Translational research · doi:10.1016/j.trsl.2007.06.005 · Cited by 56
Heritability of ischaemic stroke in women compared with men: a genetic epidemiological study.
Touzé, E., & Rothwell, P. (2007) · Lancet Neurology · doi:10.1016/s1474-4422(06)70683-4 · Cited by 59
Zeng, Z., Li, F., Gao, F., Sun, D., & Yao, L. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23210 · Cited by 56
“*Correspondence to: Lei Yao, MD, PhD, Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.”
BackgroundInfluentialYach, D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62155-8 · Cited by 60
Symptom recognition of heart attack and stroke in nine European countries: a representative survey
Mata, J., Frank, R., & Gigerenzer, G. (2012) · Health Expectations · doi:10.1111/j.1369-7625.2011.00764.x · Cited by 56
Individuals and population burdens of major trauma in the Netherlands
Holtslag, H. R., van Breeck, E., Lichtveld, R. A., Leenen, L. P. H., Lindeman, E., & van der Werken, C. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.06.033803 · Cited by 56
Cui, J., Chen, X., Zhai, X., Shi, D., Zhang, R., Zhi, X., Li, X., Gu, Z., Cao, L., Weng, W., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.021 · Cited by 56
Verma, H., Chitambar, S. D., & Gopalkrishna, V. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21331 · Cited by 56
Nieto, F. J. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.3.292 · Cited by 56
Measles Virus and Dendritic Cell Functions: How Specific Response Cohabits with Immunosuppression
Delprat, C., Vidalain, P., Valentin, H., & Rabourdin‐Combe, C. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06508-2_5 · Cited by 56
Child and youth injury prevention: A public health approach
Yanchar, N. L., Warda, L. J., Fuselli, P., & Canadian Paediatric Society (2012) · Paediatrics & Child Health · doi:10.1093/pch/17.9.511 · Cited by 55
“[3] It is projected that by 2020, this figure will increase to 8.”
BackgroundNwaka, S., Ochem, A. E., Besson, D., Ramirez, B., Fakorede, F., Botros, S. S., Inyang, U. S., Mgone, C. S., Addae-Mensah, I., Konde, V., et al. (2012) · BMC International Health and Human Rights · doi:10.1186/1472-698x-12-11 · Cited by 55
“Introduction The African continent bears the greatest burden of disease in the world today [1,2], but it has no mechanism to ensure sustainable access to the health tools needed by its people.”
BackgroundHuang, P., Huang, F., Zou, C., Sun, H., Tian, X., Yang, Y., Tang, J.-F., Yang, P., & Wang, X. (2008) · Journal of Clinical Ultrasound · doi:10.1002/jcu.20448 · Cited by 55
Fujimoto, T., Imaeda, Y., Konishi, N., Hiroe, K., Kawamura, M., Textor, G. P., Aertgeerts, K., & Kubo, K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901699j · Cited by 55
Singh, T., & Harding, R. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1102-3 · Cited by 56
“Incidence of other chronic diseases, including end-stage heart failure, renal and respiratory diseases, are projected to rise [7-9].”
BackgroundEpigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats
Hao, J., Kim, C., Ha, T., & Ahn, H. Y. (2007) · Journal of Veterinary Science · doi:10.4142/jvs.2007.8.2.121 · Cited by 55
“The single most powerful predictor for the development of heart failure is the presence of cardiac hypertrophy [18].”
BackgroundAdebisi, A. O., Laity, P. R., & Conway, B. R. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12345 · Cited by 55
“pylori, and it has been predicted to be one of the top 10 leading causes of death worldwide by 2020.([5,6]) H.”
BackgroundCoskun, U., Yıldız, A., Esen, Ö., Başkurt, M., Çakar, M. A., Kılıçkesmez, K., Orhan, L. A., & Yıldız, Ş. (2009) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-7-59 · Cited by 54
“Background Cardiovascular-related deaths are the leading cause of death both in Turkey and worldwide [1-3].”
BackgroundZhuang, G., Liu, X., Zhang, Q., Tian, F., Zhang, H., Zhang, H.-P., & Chen, W. (2012) · Clinical Lipidology · doi:10.2217/clp.12.40 · Cited by 55
Ogunmola, O. J., Olaifa, A. O., Oladapo, O. O., & Babatunde, O. A. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-89 · Cited by 57
“Background Cardiovascular disease (CVD) is the leading cause of death in adults worldwide [1].”
BackgroundAhmad, W. S. H. M. W., Zaki, W. M. D. W., & Fauzi, M. F. A. (2015) · BioMedical Engineering OnLine · doi:10.1186/s12938-015-0014-8 · Cited by 55
“Based on the survey done by [1], the mortality rates for chest diseases in 1990 are 6.3 million (ischaemic heart disease), 4.3 million (lower respiratory infections), 2.2 million (chronic obstructive pulmonary disease), 2 million (tuberculosis) and 0.9 million (lung cancer).”
BackgroundInfluentialA meta analysis of prevalence rate of hypertension in Nigerian populations
Ekwunife, O. I., & Aguwa, C. N. (2011) · Journal of Public Health and Epidemiology · doi:10.5897/jphe.9000002 · Cited by 55
Banerjee, A., De, P., Manna, B., & Chawla‐Sarkar, M. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24672 · Cited by 55
Adewole, D. A., Akanbi, S. A., Osungbade, K. O., & Bello, S. (2017) · Pan African Medical Journal · doi:10.11604/pamj.2017.27.52.11092 · Cited by 60
“This might enhance the needed motivation for them to serve as policy brokers [20] between state and non-state actors, which oftentimes tends to have conflicting political and economic interests [39-41].”
BackgroundCardiovascular gene delivery: The good road is awaiting☆
Brewster, L. P., Brey, E. M., & Greisler, H. P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.002 · Cited by 55
“Cardiovascular disease is the leading cause of mortality worldwide [1], and the most recent data from the world health organization show this trend continuing [2].”
BackgroundClinical epidemiology of acute myocardial infarction
Tavazzi, L. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70320-0 · Cited by 55
Rothwell, P. M. (2003) · Cerebrovascular Diseases · doi:10.1159/000070271 · Cited by 55
“Stroke is also the second leading cause of mortality worldwide [”
BackgroundDesign of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study
Hauser, E. R., Mooser, V., Crossman, D. C., Haines, J. L., Jones, C. H., Winkelmann, B. R., Schmidt, S., Scott, W. K., Roses, A. D., Pericak‐Vance, M. A., et al. (2003) · American Heart Journal · doi:10.1067/mhj.2003.13 · Cited by 55
Registration of Stroke through the Belgian Sentinel Network and Factors Influencing Stroke Mortality
Devroey, D., Casteren, V. V., & Buntinx, F. (2003) · Cerebrovascular Diseases · doi:10.1159/000071127 · Cited by 55
“In the industrialized world, stroke is the second cause of death. Worldwide every year about 4,000,000 subjects die after a stroke [”
BackgroundBiomarcadores en la medicina cardiovascular
Martı́n-Ventura, J. L., Blanco‐Colio, L. M., Tuñón, J., Muñoz‐García, B., Madrigal‐Matute, J., Moreno, J. A., de Céniga, M. V., & Egido, J. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)71335-1 · Cited by 55
Antioxidant vitamin supplementation in cardiovascular diseases.
Riccioni, G., Bucciarelli, T., Mancini, B., Corradi, F., Ilio, C. D., Mattei, P. A., & D’Orazio, N. (2007) · PubMed · Cited by 53
Chrysant, S. G. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001916 · Cited by 55
Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan
Abdel-Aal, N. M., Ahmad, A. T., Froelicher, E. S., Batieha, A. M., Hamza, M. M., & Ajlouni, K. M. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4510 · Cited by 54
Adunsky, A., Fleissig, Y., Levenkrohn, S., Arad, M., & Noy, S. (2002) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(02)00018-3 · Cited by 54
“In the United States and Europe stroke is the third leading cause of death and the leading cause of neurological disability (Murray and Lopaz, 1997).”
BackgroundHagimori, M., Kamiya, S., Yamaguchi, Y., & Arakawa, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.010 · Cited by 54
Krankheitskosten von COPD in Deutschland
Nowak, D., Dietrich, E. S., Oberender, P. O., Überla, K., Reitberger, U., Schlegel, C., Albers, F. C., Ruckdaeschel, S., & Welsch, R. (2004) · Pneumologie · doi:10.1055/s-2004-830143 · Cited by 54
Chichom‐Mefire, A., Mballa, G. A. E., Kenfack, M. A., Juillard, C. J., & Stevens, K. A. (2011) · Injury · doi:10.1016/j.injury.2011.10.026 · Cited by 54
“sub-Saharan Africa.(1,2) Management of injury in African settings is especially challenging due to limited resources and complex cultural contexts.”
BackgroundInfluentialRodondi, N., Yerly, P., Gabriel, A., Riesen, W. F., Burnier, M., Paccaud, F., & Bovet, P. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl733 · Cited by 54
“Cardiovascular diseases (CVD) are the leading causes of mortality and morbidity in western and developing countries [1,2].”
BackgroundRussell, J. B., Charles, E., Conteh, V., & Lisk, D. R. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.10.060 · Cited by 54
“However, in countries where there are established and well-organized stroke services, there is a significant reduction in stroke mortality and morbidity [1,2,46].”
BackgroundChallenges to Health Care for Diabetes in Africa
Whiting, D. R., Hayes, L., & Unwin, N. C. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000205 · Cited by 54
Novel candidate targets of Wnt/β-catenin signaling in hepatoma cells
Lee, H.-S., Park, M.-H., Yang, S.-J., Park, K. C., Kim, N. S., Kim, Y.-S., Kim, D. I., Yoo, H., Choi, E., & Yeom, Y. I. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.10.024 · Cited by 54
Prevalence of Stroke in an Argentine Community
Melcon, C. M., & Melcon, M. O. (2006) · Neuroepidemiology · doi:10.1159/000094978 · Cited by 54
“Stroke is a major public health problem in both developed and developing countries [”
BackgroundMolecular subtypes of the HLA-DR antigens in pulmonary tuberculosis
Dubaniewicz, A., Lewko, B., Moszkowska, G., Zamorska, B., & Stępiński, J. (2000) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(00)90073-0 · Cited by 54
Stroke Incidence in Women under 60 Years of Age Related to Alcohol Intake and Smoking Habit
Lü, M., Ye, W., Adami, H., & Weiderpass, E. (2008) · Cerebrovascular Diseases · doi:10.1159/000131669 · Cited by 54
“Heart diseases and stroke are the first and second leading causes of death for adult men and women all over the world and cause a substantial economic burden [”
BackgroundToward a framework and indicators for monitoring Roll Back Malaria
Remme, J. H. F., Binka, F. N., & Nabarro, D. N. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.76 · Cited by 54
Cerebral malaria: clinical pathophysiology and treatment features,
WARRELL, B. D. A. (1997) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034989760644 · Cited by 54
Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma
Galandi, D., & Antes, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003046.pub2 · Cited by 54
BRIC’s Growing Share of Global Health Spending and Their Diverging Pathways
Jakovljevic, M. B. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00135 · Cited by 69
Arbovirosis and potential transmission blocking vaccines
Londono-Renteria, B. L., Troupin, A., & Colpitts, T. M. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1802-0 · Cited by 53
“Infectious disease represents one the leading causes of mortality worldwide but it is especially problematic in tropical countries [1].”
BackgroundRothenbacher, D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2455 · Cited by 53
“P REVALENCE OF CORONARY heart disease (CHD) will increase within the next years, and CHD will be the number 1 cause of disability and death by the year 2020 worldwide.(1) Therefore, beside new avenues and concepts of primary prevention, improved secondary preventive strategies of CHD are necessary to reduce the burden…”
BackgroundPredictors of Intracerebral Hemorrhage Severity and Its Outcome in Japanese Stroke Patients
Hosomi, N., Naya, T., Ohkita, H., Mukai, M., Nakamura, T., Ueno, M., Dobashi, H., Murao, K., Masugata, H., Miki, T., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000172636 · Cited by 53
“Stroke is a major cause of serious disability and death throughout the world [”
BackgroundChen, S., & Suzuki, K. (2013) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2013.2284016 · Cited by 53
Ezechi, O., Kalejaiye, O. O., Gab-Okafor, C. V., Oladele, D. A., Oke, B. O., Musa, Z. A., Ekama, S., Ohwodo, H., Agahowa, E., Gbajabiamilla, T., et al. (2014) · Pan African Medical Journal · doi:10.11604/pamj.2014.17.197.2310 · Cited by 53
“Globally, hepatitis B virus (HBV) infection is most common form of chronic hepatitis and the leading cause of chronic liver diesase and liver-related deaths [1, 2].”
BackgroundWang, W., Wu, F., Fang, F., Tao, Y., & Yang, L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4820 · Cited by 53
“To address these questions, we used a stable retroviral small interfering RNA (siRNA) approach to selectively knockdown the expression of RhoC, which allowed Authors’ Affiliations: 1Liver Cancer Laboratory and 2Department of Surgery, Xiangya Hospital, Central South University, Hunan, People’s Republic of China Receive…”
BackgroundInfluentialKunjiappan, S., Saravanan, G., Pavadai, P., Murugesan, S., Arunachalam, S., Palanisamy, P., Mohan, U. P., Babkiewicz, E., Maszczyk, P., Vellaisamy, S., et al. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab5c56 · Cited by 54
“global causes of death are cardiovascular disorders, cancers, and diabetes [2].”
BackgroundHoang, V. M., Dao, L. H., Wall, S., Nguyen, T. K. C., & Byass, P. (2006) · Europe PMC (PubMed Central) · Cited by 53
Bhandari, N., Bahl, R., Taneja, S., Martines, J., & Bhan, M. K. (2002) · PubMed · Cited by 53
The role of folic acid in the prevention of cardiovascular disease
Graham, I. M., & O’Callaghan, P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00003 · Cited by 53
Bousquet, J., Ndiaye, M., Ait-Khaled, N., Annesi‐Maesano, I., & Vignola, A. M. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.02005.x · Cited by 53
“ischaemic heart disease) in order to estimate worldwide and regional cause-of-death patterns in 1990 for 14 age–sex groups in eight regions, for 107 causes (14).”
BackgroundFalchi, M., Forabosco, P., Mocci, E., Borlino, C. C., Picciau, A., Virdis, E., Persico, I., Parracciani, D., Angius, A., & Pirastu, M. (2004) · The American Journal of Human Genetics · doi:10.1086/426155 · Cited by 53
“0002-9297/2004/7506-0008$15.00 Breslow 1988; Manninen et al. 1988; Criqui et al. 1993; Gardner et al. 1996; Hokanson and Austin 1996; Stampfer et al. 1996; Murray and Lopez 1997; Lamarche et al. 1998), the leading cause of morbidity and mortality in industrialized countries.”
BackgroundInfluentialInternational Society of Hypertension (ISH)
International Society of Hypertension Writing Group (2003) · Journal of Hypertension · doi:10.1097/00004872-200304000-00002 · Cited by 88
Kim, M. J., Kim, M. J., Kim, H. S., Jeoung, J. W., & Park, K. H. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12347 · Cited by 52
“Dyslipidemia, which is usually defined as high levels of total cholesterol, TG and/or low level of HDL-C, is one of the most important modifiable risk factors for cardiovascular diseases.(44) Due to its pronounced impact on many organs of the body, dyslipidemia has also been indirectly or directly linked to a wide ran…”
BackgroundUrbin, M. A., Harris-Love, M. L., Carter, A. R., & Lang, C. E. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00119 · Cited by 52
Chen, W., Chen, C.-W., Chen, Y.-Y., Lu, C., Chen, S. C., Chen, Y.-J., & Lin, M. (2015) · International Journal of COPD · doi:10.2147/copd.s85831 · Cited by 52
“It is the fourth leading cause of chronic morbidity and mortality in the US(4) and is projected to rank fifth in 2020 in terms of burden of disease worldwide.(5,6) The natural course of COPD includes progressively declining lung function and a number of episodic exacerbations, which is defined as a worsening of respir…”
Ball, C. G., Navsaria, P. H., Kirkpatrick, A. W., Vercler, C. J., Dixon, E., Zink, J. U., Laupland, K. B., Lowe, M., Salomone, J. P., Dente, C. J., et al. (2010) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f66878 · Cited by 52
Sun, C., Chang, L., Sheu, J., Wang, C.-Y. J., Youssef, A. A., Wu, C., Chua, S. O., & Yip, H. (2007) · International Heart Journal · doi:10.1536/ihj.48.533 · Cited by 52
Prevalence of isolated systolic and isolated diastolic hypertension subtypes in China
Huang, J., Wildman, R. P., Gu, D., Muntner, P., Su, S. Y., & He, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.007 · Cited by 52
Bruno, O., Brullo, C., Schenone, S., Bondavalli, F., Ranise, A., Tognolini, M., Ballabeni, V., & Barocelli, E. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.018 · Cited by 52
Çolak, Y., Marott, J. L., Vestbo, J., & Lange, P. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.933955 · Cited by 52
“Although COPD is estimated to become the fourth leading cause of mortality worldwide by the year 2020 (4), the prevalence of obesity has increased almost exponentially during the last decades and varies from 10-20% in most European countries to approximately 32% in the United States (5, 6).”
BackgroundFěng, F., Luo, L., Tao, Y., Wu, F., & Yang, L. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0575 · Cited by 52
“It ranks as the second leading cause of cancer death among males in China (3).”
BackgroundInfluentialHigh Pathogenicity of Wild-Type Measles Virus Infection in CD150 (SLAM) Transgenic Mice
Sellin, C. I., Davoust, N., Guillaume, V., Baas, D., Belin, M., Buckland, R., Wild, T., & Horvat, B. (2006) · Journal of Virology · doi:10.1128/jvi.00209-06 · Cited by 52
“Measles virus (MV) infection remains one of the major causes of infant mortality in developing countries, accounting for almost 1 million deaths annually (34, 53).”
BackgroundNouri, F., Sarrafzadegan, N., Mohammadifard, N., Sadeghi, M., & Mansourian, M. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.153 · Cited by 52
Tian, G., Yang, S., Yuan, J.-Q., Threapleton, D. E., Zhao, Q., Chen, F., Cao, H., Jiang, T., & Li, L. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021269 · Cited by 52
Hospital Costs for Stroke Care in Singapore
Venketasubramanian, N., & Yin, A. (2000) · Cerebrovascular Diseases · doi:10.1159/000016077 · Cited by 52
Use of tamoxifen in advanced‐stage hepatocellular carcinoma
Nowak, A. K., Stockler, M. R., Chow, P. K. H., & Findlay, M. P. N. (2005) · Cancer · doi:10.1002/cncr.20963 · Cited by 52
Marie, J. C., Saltel, F., Escola, J.-M., Jurdic, P., Wild, T., & Horvat, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11952-11961.2004 · Cited by 52
“Measles virus (MV) is among the most contagious pathogens for humans, still infecting more than 40 million people and causing the death of around 1 million a year (33).”
BackgroundTissue Doppler imaging of carotid plaque wall motion: a pilot study
Ramnarine, K. V., Hartshorne, T., Sensier, Y., Naylor, M., Walker, J. K., Naylor, A. R., Panerai, R. B., & Evans, D. H. (2003) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-1-17 · Cited by 52
“Background Cardiovascular disease accounts for around half the deaths in the Western world, with stroke being the third leading cause of death and disability worldwide [1].”
BackgroundBell, R. M., & Yellon, D. M. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00190.x · Cited by 51
“Ischemic heart disease, resultant from coronary artery disease and acute myocardial infarction (AMI), is the largest single cause of death worldwide [1].”
BackgroundRisk of mortality for dementia in a developing country: the Yoruba in Nigeria
Perkins, A. J., Hui, S. L., Ogunniyi, A. O., Gureje, O., Baiyewu, O., Unverzagt, F. W., Gao, S., Hall, K. S., Musick, B. S., & Hendrie, H. C. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.643 · Cited by 51
Kuningas, M., May, L., Tamm, R., van Bodegom, D., van den Biggelaar, A. H. J., Meij, J. J., Frölich, M., Ziem, J. B., Suchiman, H. E. D., Metspalu, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007795 · Cited by 45
“However, the proposed evolutionary selection for variants mediating resistance to infectious diseases has been taken for granted [12–14].”
BackgroundB cells in the aging immune system: time to consider B‐1 cells
Holodick, N. E., & Rothstein, T. L. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12825 · Cited by 43
Metadata
- Authors
- Murray, C. J., & Lopez, A. D.
- Affiliations
- Harvard University (US)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-05
- Volume
- 349
- Issue
- 9061
- Pages
- 1269-1276
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2108361166
- Cited by
- 4,043
- References
- 28
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 54 · 2023: 51 · 2022: 82 · 2021: 100 · 2020: 93 · 2019: 102 · 2018: 100 · 2017: 124 · 2016: 141 · 2015: 168 · 2014: 207 · 2013: 185 · 2012: 211
- FWCI
- 412.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- causes of death, mortality estimates, global burden of disease, non-communicable diseases, infectious diseases, injuries, ischemic heart disease, cerebrovascular disease, lower respiratory tract infection, diarrhoeal diseases, perinatal disorders, maternal disorders, nutritional disorders, developing countries, sub-Saharan Africa, vital registration data
- MeSH terms
- Adolescent, Adult, Aged, Cause of Death, Cerebrovascular Disorders, Child, Child, Preschool, Communicable Diseases, Diarrhea, Disease, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Mortality, Neoplasms, Nutrition Disorders, Respiratory Tract Diseases, Risk Factors, Global Health, Wounds and Injuries, Myocardial Ischemia, Cost of Illness, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review